Whether you're interested in partnering on the HUNTER Trial, have media inquiries, or simply want to learn more about our work we'd love to hear from you. Our team responds to all serious inquiries within 48 hours.
For partnership inquiries, protocol questions, or general correspondence:
collaborate@hunteriatrial.org
Media Inquiries:
media@hunteriatrial.org
Available Monday–Friday, 9:00 AM – 5:00 PM WAT (West Africa Time):
+447426112316For urgent partnership matters, please email first and we'll schedule a call within 24 hours.
HUNTER Trial Research Office
13 Sands Close
Sheffield, UK S14 1QP
Office visits by appointment only. Please contact us to schedule.
Fill out the form below and we'll get back to you within 48 hours. For partnership inquiries, please visit our Collaborate page for more detailed partnership forms.
HUNTER Trial Research Office
13 Sands Close
Sheffield,
UK S14 1QP
Monday – Friday: 9:00 AM – 5:00 PM WAT
Saturday – Sunday: Closed
Office visits by appointment only
General: info@hunteriatrial.org
Partnerships: collaborate@hunteriatrial.org
Media: media@hunteriatrial.org
Main Office: +447426112316
WhatsApp: +447426112316
We understand that timely communication is critical for potential partnerships and collaborations. That's why we commit to responding to all serious inquiries within 48 hours during business days. For urgent partnership matters, we often respond within 24 hours.
Interested in collaborating as a clinical site, PI, funder, or industry partner? Visit our dedicated partnerships page for detailed information and collaboration models.
Explore PartnershipsGet an overview of the HUNTER Trial design, endpoints, timeline, and eligibility criteria. Download the Protocol-at-a-Glance or request full protocol access.
View Study DetailsLearn about Hunteria umbellata ethnobotany, mechanism of action, preclinical evidence, and the scientific rationale for early diabetes remission trials.
Explore the ScienceCommon questions about IP ownership, regulatory pathways, publication rights, budget details, and trial timelines answered in our comprehensive FAQ document.
Read FAQ